Pharmion Corp. (extinct)

Pharmion Corp. (extinct)

Pharmion Corp. (extinct)

Overview
Date Founded

1999

Headquarters

2525 28th Street,Suite 200,Boulder, CO 80301

Type of Company

Private

Employees (Worldwide)

417

Industries

Pharmaceuticals

Company Description

Pharmion Corp. engages in the development and commercialization of products for the treatment of hematology and oncology patients. It has operations in Switzerland, Israel, and Philippines. The company was founded by Patrick J. Mahaffy in 1999 and is headquartered in Boulder, CO.

Contact Data
Trying to get in touch with decision makers at Pharmion Corp.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Paths to Pharmion Corp.
Potential Connections via
Relationship Science
You
Pharmion Corp.
Recent Transactions
Details Hidden

Celgene Corp. purchases Pharmion Corp.

Details Hidden

Pharmion Corp. issued Common Stock

Details Hidden

Pharmion Corp. purchases Cabrellis Pharmaceuticals Corp.

Transaction Advisors
Underwriter

Advised onPharmion Corp. issued Common Stock

Investment Advisor

Advised onCelgene Corp. purchases Pharmion Corp.

Underwriter

Advised onPharmion Corp. issued Common Stock

Legal Advisor

Advised onCelgene Corp. purchases Pharmion Corp.

Legal Advisor

Advised onCelgene Corp. purchases Pharmion Corp.

Associate

Advised onCelgene Corp. purchases Pharmion Corp.

Advisors & Consultants
Legal Advisor

Partner at Willkie Farr & Gallagher LLP

Key Stats and Financials As of 2019
Market Capitalization
Total Enterprise Value
Earnings Per Share
Revenue
$24.3M
Investors
Details Hidden

Chairman & Chief Executive Officer at SuviCa, Inc.

Details Hidden

Co-Founder at Clovis Oncology, Inc.

Details Hidden

Domain Associates invests exclusively in emerging life sciences companies. The firm focuses on pharmaceuticals, specialty pharmaceuticals and medical devices and they are also interested in biomaterials, bioinstrumentation and diagnostics. They prefer to be part of the first institutional financing round of a company. They look for companies with outstanding technology addressing unmet needs in very large markets led by exceptional management. Once invested, Domain takes an active role in guiding the growth of the company. They take a seat on the Board of Directors in the vast majority of cases. Most of their investments are in private companies, but they also invest in small-cap public healthcare companies that are implementing a new corporate strategy.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Pharmion Corp.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Pharmion Corp.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Pharmion Corp..